Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FX3PD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $179,122
Award facts
- Contract value 100% obligated
- $179,121.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $179,121.59 to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pens on October 20, 2025, with completion scheduled for October 21, 2025. The contract utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026.
Dupixent is a biologic medication used to treat conditions such as moderate-to-severe atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps, making it a critical therapeutic agent for military and veteran healthcare systems. This award exemplifies AmerisourceBergen Drug Corp's established role as a primary supplier of specialty pharmaceuticals and medical commodities to federal healthcare programs, including the Defense Health Agency and U.S. Coast Guard. The company's extensive federal contract portfolio demonstrates consistent capability in delivering brand-name and generic medications across multiple therapeutic domains through competitive procurement processes.
Quick answers
Who was awarded contract SPE2DB26FX3PD?
SPE2DB26FX3PD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 20, 2025.
How much is contract SPE2DB26FX3PD worth?
The government has obligated $179,122 on SPE2DB26FX3PD.
Is contract SPE2DB26FX3PD an order under another contract?
Yes. SPE2DB26FX3PD is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX3PD competed?
The extent of competition for SPE2DB26FX3PD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award